A Study of Atezolizumab With or Without Tiragolumab in Participants With Unresectable Esophageal Squamous Cell Carcinoma Whose Cancers Have Not Progressed Following Definitive Concurrent Chemoradiotherapy
760 patients around the world
Available in Argentina, United States, Brazil
Hoffmann-La Roche
20Research sites
760Patients around the world
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Sites
Instituto de Diagnóstico e Investigaciones Metabólicas - IDIM - sede centro - CABA
Recruiting
Libertad 836 - Libertad 836, Ciudad de Buenos Aireswww.idim.com.ar/
Fundación Cori para la Investigación y Prevención del Cáncer - La Rioja
Recruiting
Dorrego 269, La Rioja
Fundación CENIT para la Investigación en Neurociencias
Recruiting
Juncal 2222, C1125 CABA, Argentina
Fundación Favaloro para la Docencia e Investigación Médica - CABA, Buenos Aires
Recruiting
Av. Belgrano 1782, CABA, Buenos Aires
Instituto de Ensino e Pesquisa Clinica do Ceara
Recruiting
Rua Coronel Jucá, 1952, Fortaleza, Ceara
Hospital de Caridade de Ijuí
Recruiting
Av. David José Martins, 152 - Centro, Ijuí - RS, 98700-000